Patents

US 8906866 B2: Antibiotic compositions for the treatment of gram negative infections

Granted
2014-12-09
Filed
2013-03-15 application 13835470
Type
Utility · 9 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are novel compounds and novel protected compounds that can be derived from polymyxin, including, e.g., polymyxin A. The novel compounds have antibacterial properties against a diverse range of Gram negative bacteria and reduced toxicity compared to polymyxins such as polymyxin A. Also provided are antibacterial pharmaceutical compositions containing the novel compounds and novel protected compounds, as well as methods for preparing the antibacterial compounds and protected compounds.

Source: PVGPATDIS, file of 2026-04-10 (ipg141209.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
BioSource Pharm, Inc. 4 patentsUS company or organizationSpring Valley, NYPVGPATDIS, file of 2026-04-10
Cubist Pharmaceuticals LLC 29 patentsForeign company or organizationLexington, MACUBIST PHARMACEUTICALS INC SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
William V. CurranPearl River, NY2PVGPATDIS, file of 2026-04-10
Christopher Matthew LiuSomerville, MA9PVGPATDIS, file of 2026-04-10
Amy C. D. BombardierMaynard, MA2PVGPATDIS, file of 2026-04-10
Richard A. LeeseSuffern, NY4PVGPATDIS, file of 2026-04-10
You Seok HwangConcord, MA7PVGPATDIS, file of 2026-04-10
Blaise S. LippaActon, MA22PVGPATDIS, file of 2026-04-10
Yanzhi ZhangEast Walpole, MA2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K7/62PVGPATDIS, file of 2026-04-10
A01NPreservation of bodies of humans or animals or plants or parts thereof ; biocides, e.g. as disinfectants, as pesticides or as herbicides ; pest repellants or attractants; plant growth regulatorsA01N43/713PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K38/12PVGPATDIS, file of 2026-04-10
Y02ATechnologies for adaptation to climate changeY02A50/30PVGPATDIS, file of 2026-04-10
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digestsY10S930/19PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-08-08Merger
Merger
MERCK SHARP & DOHME CORP. signed 2022-04-07MERCK SHARP & DOHME LLC RAHWAY, NJ61102/145PASDL, file of 2026-10-15
2015-07-09Name change
Change of name
CUBIST PHARMACEUTICALS, INC. signed 2015-06-29CUBIST PHARMACEUTICALS LLC KENILWORTH, NJ36084/448ECORSEXC, file of 2026-09-25
2015-07-09Assignment
Assignment of assignor's interest
CUBIST PHARMACEUTICALS LLC signed 2015-07-09MERCK SHARP & DOHME CORP. RAHWAY, NJ36046/602ECORSEXC, file of 2026-09-25
2014-01-06Assignment
Assignment of assignor's interest
ZHANG, YANZHI signed 2011-08-17
BOMBARDIER, AMY C.D. signed 2011-08-19
HWANG, YOU SEOK signed 2011-08-19
LIPPA, BLAISE S. signed 2011-08-19
LIU, CHRISTOPHER M. signed 2011-08-19
CUBIST PHARMACEUTICALS, INC. LEXINGTON, MA31896/452ECORSEXC, file of 2026-09-25
2014-01-06Assignment
Assignment of assignor's interest
CURRAN, WILLIAM V. signed 2011-09-06
LEESE, RICHARD A. signed 2011-09-06
BIOSOURCE PHARM, INC. SPRING VALLEY, NY31896/422ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.